Lishewski, Phillipp
Fischer, Maike
Tas, Kerem Tuna
Sheikhzadeh, Fatima Frosan
Smalec, Edgar
Agolli, Linda
Nimsky, Christopher
Kemmling, André
Habermehl, Daniel
Zink, Klemens
Gawish, Ahmed https://orcid.org/0000-0001-5557-7438
Adeberg, Sebastian
Funding for this research was provided by:
Philipps-Universität Marburg
Article History
Received: 28 January 2026
Accepted: 3 March 2026
First Online: 27 March 2026
Declarations
:
: S. Adeberg: honoraria/travel reimbursement from Accuray Inc., AstraZeneca GmbH, Servier, Bristol Myers Squibb GmbH & Co., MSD, Novocure GmbH, Merck KGaA, Fakultät Heidelberg, Fakultät Marburg, Sanofi Genzyme; research cooperations with Novocure GmbH; scientific advisory function for Accuray Inc., Sanofi Genzyme, Servier, Novartis, Novocure GmbH, Merck KGaA. P. Lishewski, M. Fischer, K.T. Tas, F.F. Sheikhzadeh, E. Smalec, L. Agolli, C. Nimsky, A. Kemmling, D. Habermehl, K. Zink, and A. Gawish declare that they have no competing interests.
: The study was approved by the ethics committee of the Philipps University Marburg (nr. 24-138-RS at 03.06.2024) and was carried out in accordance with the Declaration of Helsinki. The requirement for informed consent was waived because of the retrospective design.